Liquidia (LQDA) Gross Margin Growth (1y) (2021 - 2026)
Liquidia (LQDA) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 164.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -378.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -397.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -173.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 156.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -92.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 88.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Liquidia | 6.40 Bn | 6.12 Bn | 160.92 Mn | 835.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 835.00 |
| Mar 31, 2026 | 4,028.00 |
| Dec 31, 2025 | 4,084.00 |
| Sep 30, 2025 | 3,096.00 |
| Jun 30, 2025 | 2,618.00 |
| Mar 31, 2025 | 74.00 |
| Dec 31, 2024 | -2,450.00 |
| Sep 30, 2024 | -1,969.00 |
| Jun 30, 2024 | -2,678.00 |
| Mar 31, 2024 | -3,480.00 |
| Dec 31, 2023 | -897.00 |
| Sep 30, 2023 | 788.00 |
| Jun 30, 2023 | 464.00 |
| Mar 31, 2023 | 532.00 |
| Dec 31, 2022 | 963.00 |
| Sep 30, 2022 | 462.00 |
| Jun 30, 2022 | 249.00 |
| Mar 31, 2022 | 263.00 |
| Dec 31, 2021 | 956.00 |